...culture and mouse studies identified a bicyclic HSD17B2 inhibitor that could help treat bone fractures ElexoPharm GmbH...

...bone stiffness and callus volume at the fracture site compared with vehicle. Next steps by ElexoPharm GmbH...
...online Jan. 15, 2019 doi:10.1021/acs.jmedchem.8b01493 CONTACT: Chris J. van Koppen, ElexoPharm GmbH, Saarbrücken, Germany email: vankoppen@elexopharm.de Hongjiang Li ElexoPharm GmbH Hydroxysteroid...

...million) to a consortium to develop low molecular weight inhibitors of angiogenesis in colorectal cancer. ElexoPharm...
...of public funding agencies from Austria, Belgium, Finland, France, Germany, Hungary, Italy, Russia and Spain. ElexoPharm GmbH...

...A consortium consisting of Khondrion, ElexoPharm, Pharmacelsus and Radboud received a three-year €2.1 million ($2.7 million...
...of Education and Research, under the Eurostars R&D program, to discover therapies for mitochondrial diseases. ElexoPharm...
...the university will conduct in vivo preclinical testing on selected compounds. Details were not disclosed. ElexoPharm GmbH...

...is responsible for all development, regulatory filings, manufacturing and commercialization of compounds under the deal. ElexoPharm...
...front and is eligible for up to €32.3 million ($39.9 million) in milestones, plus royalties. ElexoPharm GmbH...